Table 2.
Group 1:low methyl | 2: intermediate | 3:high methyl | p value | |
---|---|---|---|---|
No | 99 | 40 | 22 | |
Age | ||||
mean | 60.8 | 59.3 | 64.3 | 0.257 |
Sex | ||||
Male | 60 | 22 | 11 | 0.608 |
Female | 39 | 18 | 11 | |
Site | ||||
Proximal | 42 | 16 | 18 | 0.002* |
Distal | 57 | 24 | 4 | |
Histology | ||||
Adeno | 94 | 38 | 21 | 0.995 |
Mucinous | 5 | 2 | 1 | |
Differentiation | ||||
WD | 12 | 5 | 1 | 0.646 |
MD | 78 | 32 | 18 | |
PD | 4 | 1 | 2 | |
T stage | ||||
1 | 3 | 0 | 0 | 0.344 |
2 | 8 | 5 | 2 | |
3 | 74 | 26 | 13 | |
4 | 14 | 9 | 7 | |
N stage | ||||
1 | 70 | 26 | 15 | 0.802 |
2 | 29 | 14 | 7 | |
Recurrence | ||||
No | 67 | 29 | 12 | 0.424 |
Yes | 28 | 11 | 9 | |
LINE1 | ||||
mean±SD | 50.1±8.4 | 50.4±4.6 | 53.6±6.2 | 0.14 |
MSI status** | ||||
MSS or MSI-L | 47 | 21 | 6 | 0.034* |
MSI-H | 10 | 2 | 5 |
WD, well differentiated; MD, moderately differentiated; PD, Poorly differentiated; Adeno, adenocarcinoma: Mucinous, mucinous adenocarcinoma
significant difference among groups by K means clustering analysis
available for a subset of patients only